• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玉屏风散通过JAK2-STAT3信号通路促进树突状细胞成熟,改善肝细胞癌微环境的免疫抑制。

Yu-Ping-Feng-San improve the immunosuppression of microenvironment in hepatocellular carcinoma by promoting the maturation of DCs through the JAK2-STAT3 pathway.

作者信息

Yao Fei, Yuan Qin, Yan Yichao, Liang Guoqiang, Zhou Liang, Xu Heng, Gao Shaomei, Zou Ting, Zhang Lurong

机构信息

Central Laboratory, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, 215000, Jiangsu, China.

Clinical Pharmaceutical Laboratory of Traditional Chinese Medicine, Suzhou Academy of Wumen Chinese Medicine, Suzhou, 215000, Jiangsu, China.

出版信息

Sci Rep. 2024 Dec 28;14(1):31522. doi: 10.1038/s41598-024-83197-7.

DOI:10.1038/s41598-024-83197-7
PMID:39733089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11682348/
Abstract

Yu-Ping-Feng-San (YPF) is a famous classical Chinese medicine formula known for its ability to boost immunity. YPF has been applied to enhance the immune status of tumor patients in clinical practice. However, there is still a lack of research on its immune regulatory effects and mechanisms in the tumor microenvironment. This study was designed to investigate the effects and mechanism of YPF on improving the immune suppression state of hepatocellular carcinoma (HCC) microenvironment. In an orthotopic mouse model of HCC, YPF improved the immune microenvironment of HCC immunosuppression, enhanced the maturation of dendritic cells (DCs), promoted the release of IL-12, and decreased the presence of JAK2, p-JAK2, STAT3, and p-STAT3 proteins in both tumor tissue and paracancerous tissues. YPF also could promote the maturation and reduce the activation of JAK2, p-JAK2, STAT3, and p-STAT3 proteins of mouse bone marrow-derived DCs induced by culture medium or tumor supernatant in vitro. Transient transfection of siRNA-STAT3 with DCs resulted in an increase in its maturation and its secretion of IL-12. On the whole, these combined effects of YPF served to ameliorate the HCC immune suppression microenvironment, which conducive to immune cells play the role of immune surveillance and killing liver cancer cells. The mechanisms of these combined effects were, at least in part, related to its inhibition of the activated JAK2-STAT3 signaling pathway in DCs within the HCC microenvironment.

摘要

玉屏风散(YPF)是一种著名的经典中药方剂,以其增强免疫力的能力而闻名。YPF已在临床实践中用于提高肿瘤患者的免疫状态。然而,关于其在肿瘤微环境中的免疫调节作用和机制仍缺乏研究。本研究旨在探讨YPF改善肝细胞癌(HCC)微环境免疫抑制状态的作用及机制。在HCC原位小鼠模型中,YPF改善了HCC免疫抑制的免疫微环境,增强了树突状细胞(DCs)的成熟,促进了IL-12的释放,并降低了肿瘤组织和癌旁组织中JAK2、p-JAK2、STAT3和p-STAT3蛋白的表达。YPF还可以促进体外培养基或肿瘤上清液诱导的小鼠骨髓来源DCs的成熟,并降低JAK2、p-JAK2、STAT3和p-STAT3蛋白的激活。用DCs瞬时转染siRNA-STAT3导致其成熟及IL-12分泌增加。总体而言,YPF的这些联合作用有助于改善HCC免疫抑制微环境,有利于免疫细胞发挥免疫监视和杀伤肝癌细胞的作用。这些联合作用的机制至少部分与其抑制HCC微环境中DCs内激活的JAK2-STAT3信号通路有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dda/11682348/8ab3c896cc01/41598_2024_83197_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dda/11682348/82dbd82fa9a0/41598_2024_83197_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dda/11682348/1b970000c354/41598_2024_83197_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dda/11682348/6da15327e558/41598_2024_83197_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dda/11682348/d990737201ff/41598_2024_83197_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dda/11682348/8ab3c896cc01/41598_2024_83197_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dda/11682348/82dbd82fa9a0/41598_2024_83197_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dda/11682348/1b970000c354/41598_2024_83197_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dda/11682348/6da15327e558/41598_2024_83197_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dda/11682348/d990737201ff/41598_2024_83197_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dda/11682348/8ab3c896cc01/41598_2024_83197_Fig5_HTML.jpg

相似文献

1
Yu-Ping-Feng-San improve the immunosuppression of microenvironment in hepatocellular carcinoma by promoting the maturation of DCs through the JAK2-STAT3 pathway.玉屏风散通过JAK2-STAT3信号通路促进树突状细胞成熟,改善肝细胞癌微环境的免疫抑制。
Sci Rep. 2024 Dec 28;14(1):31522. doi: 10.1038/s41598-024-83197-7.
2
The inducible effect of LBP on maturation of dendritic cells and the related immune signaling pathways in hepatocellular carcinoma (HCC).LBP 对肝癌 (HCC) 树突状细胞成熟的诱导作用及其相关免疫信号通路。
Curr Drug Deliv. 2012 Jul;9(4):414-20. doi: 10.2174/156720112801323107.
3
Curcumin Inhibits the Growth of Hepatocellular Carcinoma the MARCH1-mediated Modulation of JAK2/STAT3 Signaling.姜黄素通过MARCH1介导的JAK2/STAT3信号调节抑制肝癌细胞生长。
Recent Pat Anticancer Drug Discov. 2025;20(2):145-157. doi: 10.2174/0115748928261490231124055059.
4
NUSAP1 Promotes Immunity and Apoptosis by the SHCBP1/JAK2/STAT3 Phosphorylation Pathway to Induce Dendritic Cell Generation in Hepatocellular Carcinoma.NUSAP1通过SHCBP1/JAK2/STAT3磷酸化途径促进免疫和细胞凋亡,以诱导肝细胞癌中树突状细胞的生成。
J Immunother. 2025;48(2):46-57. doi: 10.1097/CJI.0000000000000531. Epub 2024 Jul 9.
5
IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma.IL-17 通过 AKT 依赖性 IL-6/JAK2/STAT3 激活诱导肝癌进展。
Mol Cancer. 2011 Dec 15;10:150. doi: 10.1186/1476-4598-10-150.
6
Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2/STAT3 and PI3K/Akt pathways in an EphB4-dependent manner.斑蝥素通过 EphB4 依赖性调节 JAK2/STAT3 和 PI3K/Akt 通路抑制肝癌发展。
Pharmacol Res. 2020 Aug;158:104868. doi: 10.1016/j.phrs.2020.104868. Epub 2020 May 12.
7
Ginsenoside Rh1 regulates the immune microenvironment of hepatocellular carcinoma via the glucocorticoid receptor.人参皂苷Rh1通过糖皮质激素受体调节肝细胞癌的免疫微环境。
J Integr Med. 2024 Nov;22(6):709-718. doi: 10.1016/j.joim.2024.09.004. Epub 2024 Sep 30.
8
Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3.大黄素通过阻断信号转导和转录激活因子3(STAT3)的激活,在原位肝癌模型中抑制肿瘤生长并诱导细胞凋亡。
Br J Pharmacol. 2013 Oct;170(4):807-21. doi: 10.1111/bph.12302.
9
Yu-Ping-Feng-San alleviates inflammation in atopic dermatitis mice by TLR4/MyD88/NF-κB pathway.玉屏风散通过TLR4/MyD88/NF-κB信号通路减轻特应性皮炎小鼠的炎症反应。
J Ethnopharmacol. 2024 Jul 15;329:118092. doi: 10.1016/j.jep.2024.118092. Epub 2024 Apr 9.
10
CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.环状 SOD2 通过诱导表观遗传改变驱动肝细胞癌进展,通过激活 JAK2/STAT3 信号通路。
J Exp Clin Cancer Res. 2020 Nov 25;39(1):259. doi: 10.1186/s13046-020-01769-7.

本文引用的文献

1
Potential molecular metabolic mechanisms underlying the effects of cimifugin in gastric cancer through single-cell and bulk RNA sequencing combined with network pharmacology.通过单细胞和批量RNA测序结合网络药理学研究升麻素苷在胃癌中作用的潜在分子代谢机制
J Gastrointest Oncol. 2024 Aug 31;15(4):1409-1430. doi: 10.21037/jgo-24-413. Epub 2024 Aug 19.
2
Anti-tumor effect and hepatotoxicity mechanisms of psoralen.补骨脂素的抗肿瘤作用及肝毒性机制
Front Pharmacol. 2024 Aug 5;15:1442700. doi: 10.3389/fphar.2024.1442700. eCollection 2024.
3
Exploring the multi-targeting phytoestrogen potential of Calycosin for cancer treatment: A review.
探索毛蕊异黄酮用于癌症治疗的多靶点植物雌激素潜力:综述
Medicine (Baltimore). 2024 May 3;103(18):e38023. doi: 10.1097/MD.0000000000038023.
4
CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses.树突状细胞表达 CD5 指导 T 细胞免疫并维持免疫治疗反应。
Science. 2023 Feb 17;379(6633):eabg2752. doi: 10.1126/science.abg2752.
5
The mononuclear phagocyte system in hepatocellular carcinoma.原发性肝癌的单核吞噬细胞系统。
World J Gastroenterol. 2022 Dec 7;28(45):6345-6355. doi: 10.3748/wjg.v28.i45.6345.
6
Evolving therapeutic landscape of advanced hepatocellular carcinoma.晚期肝细胞癌不断演变的治疗格局。
Nat Rev Gastroenterol Hepatol. 2023 Apr;20(4):203-222. doi: 10.1038/s41575-022-00704-9. Epub 2022 Nov 11.
7
Dendritic-Cell-Vaccine-Based Immunotherapy for Hepatocellular Carcinoma: Clinical Trials and Recent Preclinical Studies.基于树突状细胞疫苗的肝细胞癌免疫疗法:临床试验与近期临床前研究
Cancers (Basel). 2022 Sep 8;14(18):4380. doi: 10.3390/cancers14184380.
8
Frontier progress of the combination of modern medicine and traditional Chinese medicine in the treatment of hepatocellular carcinoma.现代医学与中医药结合治疗肝细胞癌的前沿进展
Chin Med. 2022 Jul 30;17(1):90. doi: 10.1186/s13020-022-00645-0.
9
The Effect of Calycosin-7-O-β-D-Glucoside and its Synergistic Augmentation of Cisplatin-induced Apoptosis in SK-OV-3 Cells.毛蕊异黄酮-7-O-β-D-葡萄糖苷及其与顺铂协同诱导 SK-OV-3 细胞凋亡的作用。
Curr Pharm Des. 2022;28(26):2161-2166. doi: 10.2174/1381612828666220610164100.
10
Targeted inhibition of STAT3 induces immunogenic cell death of hepatocellular carcinoma cells via glycolysis.靶向抑制 STAT3 通过糖酵解诱导肝癌细胞发生免疫原性细胞死亡。
Mol Oncol. 2022 Aug;16(15):2861-2880. doi: 10.1002/1878-0261.13263. Epub 2022 Jun 27.